2012-2014

M.Pharm (Pharmacology)

Neuroprotective effects of various pharmacological interventions in experimental Alzheimer's disease

2008-2012

B. Pharmacy

Bharat Instituet of technology Partapur By-pass Meerut, India.

Project submitted on

Adverse durg reaction in 2011

2012-2014

M.Pharmacy (Pharmacology)

2008-2012

B.Pharmacy

Reading research articles, find new target related to reseach, watching movies

Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer's disease.

Jayant S, Sharma BM, Bansal R, Sharma B.

Pharmacol Biochem Behav. 2016 Jan;140:39-50. doi: 10.1016/j.pbb.2015.11.006. Epub 2015 Nov 11.

PMID:26577751

Protective effect of transient receptor potential vanilloid subtype 1 (TRPV1) modulator, against behavioral, biochemical and structural damage in experimental models of Alzheimer's disease.

Jayant S, Sharma BM, Sharma B.

Brain Res. 2016 Apr 12. pii: S0006-8993(16)30230-X. doi: 10.1016/j.brainres.2016.04.022. [Epub ahead of print]

PMID:27084583

Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia

Jayant S, Sharma B.

Curr Neurovasc Res. 2016 Sep 6. [Epub ahead of print]